Obesity drug semaglutide studied in routine care – but trial stopped early
NCT ID NCT07081178
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study followed 100 adults with obesity who were already prescribed semaglutide by their doctors. Researchers wanted to see how much weight people lost over 12 months while using the drug along with lifestyle changes in everyday practice. The study was terminated early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, 13597, Germany
Conditions
Explore the condition pages connected to this study.